Current Scenario and Future Perspectives of Porcine Corneal Xenotransplantation
Heloisa Nascimento,Thaís M M Martins,Rodrigo Moreira,Gabriel Barbieri,Pedro Pires,Lucimeire N Carvalho,Larissa R Rosa,Augusto Almeida,Michelle Silva Araujo,Carmen Luz Pessuti,Henrique Ferrer,José Álvaro Pereira Gomes,Rubens Belfort Jr,Silvano Raia
DOI: https://doi.org/10.1097/ICO.0000000000003723
IF: 3.152
2024-10-15
Cornea
Abstract:Corneal diseases represent a significant cause of blindness worldwide, with corneal transplantation being an effective treatment to prevent vision loss. Despite substantial advances in transplantation techniques, the demand for donor corneas exceeds the available supply, particularly in developing countries. Cornea xenotransplantation has emerged as a promising strategy to address the worldwide scarcity, notably using porcine corneas. In addition to the inherent immune privilege of the cornea, the low cost of porcine breeding and the anatomical and physiological similarities between humans and pigs have made porcine corneas a viable alternative. Nonetheless, ethical concerns, specifically the risk of xenozoonotic transmission and the necessity for stringent biosafety measures, remain significant obstacles. Moreover, the success of xenotransplantation is compromised by innate and adaptive immune responses, which requires meticulous consideration and further studies. Despite these challenges, recent breakthroughs have further contributed to reducing immunogenicity while preserving the corneal architecture. Advances in genetic engineering, such as the use of CRISPR-Cas9 to eliminate critical porcine antigens, have shown promise for mitigating immune reactions. Additionally, new immunosuppressive protocols, such as have techniques like decellularization and the use of porcine-derived acellular matrices, have greatly increased graft survival in preclinical models. Future research must focus on refining immunomodulatory strategies and improving graft preparation techniques to ensure the long-term survival and safety of porcine corneal xenotransplantation in clinical trials in humans.